NCT04383067 2021-02-11A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma PatientsSheba Medical CenterPhase 2 Unknown20 enrolled